These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22843237)

  • 1. Molecular characterization of Mtb-OMP decarboxylase by modeling, docking and dynamic studies.
    Madhusudana P; Babajan B; Chaitanya M; Anuradha CM; Shobharani C; Chikati R; Kumar CS; Rao KR; Poda S
    Interdiscip Sci; 2012 Jun; 4(2):142-52. PubMed ID: 22843237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of orotidine 5'-monophosphate decarboxylase in complex with the top three OMP, BMP, and PMP ligands by molecular dynamics simulation.
    Jamshidi S; Jalili S; Rafii-Tabar H
    J Biomol Struct Dyn; 2015; 33(2):404-17. PubMed ID: 24559040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
    Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
    Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase.
    Tokuoka K; Kusakari Y; Krungkrai SR; Matsumura H; Kai Y; Krungkrai J; Horii T; Inoue T
    J Biochem; 2008 Jan; 143(1):69-78. PubMed ID: 17981823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.
    Chaitanya M; Babajan B; Anuradha CM; Naveen M; Rajasekhar C; Madhusudana P; Kumar CS
    J Mol Model; 2010 Aug; 16(8):1357-67. PubMed ID: 20140471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.
    Pulaganti M; Banaganapalli B; Mulakayala C; Chitta SK; C M A
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1407-32. PubMed ID: 24203275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase.
    Takashima Y; Mizohata E; Krungkrai SR; Fukunishi Y; Kinoshita T; Sakata T; Matsumura H; Krungkrai J; Horii T; Inoue T
    J Biochem; 2012 Aug; 152(2):133-8. PubMed ID: 22740703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemistry of the reaction determines the invariant amino acids during the evolution and divergence of orotidine 5'-monophosphate decarboxylase.
    Traut TW; Temple BR
    J Biol Chem; 2000 Sep; 275(37):28675-81. PubMed ID: 10893234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamic study of orotidine-5'-monophosphate decarboxylase in ground state and in intermediate state: a role of the 203-218 loop dynamics.
    Hur S; Bruice TC
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9668-73. PubMed ID: 12107279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling, molecular dynamics and inhibitor binding study on MurD ligase of Mycobacterium tuberculosis.
    Arvind A; Kumar V; Saravanan P; Mohan CG
    Interdiscip Sci; 2012 Sep; 4(3):223-38. PubMed ID: 23292696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of the relationship between active site loop size and thermodynamic activation parameters for orotidine 5'-monophosphate decarboxylase from mesophilic and thermophilic organisms.
    Toth K; Amyes TL; Wood BM; Chan KK; Gerlt JA; Richard JP
    Biochemistry; 2009 Aug; 48(33):8006-13. PubMed ID: 19618917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon isotope effect study on orotidine 5'-monophosphate decarboxylase: support for an anionic intermediate.
    Van Vleet JL; Reinhardt LA; Miller BG; Sievers A; Cleland WW
    Biochemistry; 2008 Jan; 47(2):798-803. PubMed ID: 18081312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No metal cofactor in orotidine 5'-monophosphate decarboxylase.
    Cui W; DeWitt JG; Miller SM; Wu W
    Biochem Biophys Res Commun; 1999 May; 259(1):133-5. PubMed ID: 10334928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
    Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
    J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantum and classical simulations of orotidine monophosphate decarboxylase: support for a direct decarboxylation mechanism.
    Vardi-Kilshtain A; Doron D; Major DT
    Biochemistry; 2013 Jun; 52(25):4382-90. PubMed ID: 23692207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proficient enzyme: insights on the mechanism of orotidine monophosphate decarboxylase from computer simulations.
    Raugei S; Cascella M; Carloni P
    J Am Chem Soc; 2004 Dec; 126(48):15730-7. PubMed ID: 15571395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrogation of the active site of OMP decarboxylase from Escherichia coli with a substrate analogue bearing an anionic group at C6.
    Thirumalairajan S; Mahaney B; Bearne SL
    Chem Commun (Camb); 2010 May; 46(18):3158-60. PubMed ID: 20424759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orotidine Monophosphate Decarboxylase--A Fascinating Workhorse Enzyme with Therapeutic Potential.
    Fujihashi M; Mnpotra JS; Mishra RK; Pai EF; Kotra LP
    J Genet Genomics; 2015 May; 42(5):221-34. PubMed ID: 26059770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.